Send me real-time posts from this site at my email
Zacks

How Hard Will Coronavirus Hit Omnicom's (OMC) Q3 Earnings?

Omnicom Group Inc. OMC is scheduled to report third-quarter 2020 results on Oct 27, before the bell.

Expectations in Detail

The Zacks Consensus Estimate for revenues is pegged at $3.14 billion, indicating a 13.5% decline from the year-ago quarter’s actual figure. The top line is expected to predominantly reflect the impact of decline in organic revenues, resulting from drop in business activities due to the coronavirus pandemic. 

Decline in acquisition revenues, net of disposition revenues, and unfavorable foreign-exchange movements are also expected to have weighed on the top line. In second-quarter 2020, total revenues of $2.8 billion decreased 24.7% year over year.

The Zacks Consensus Estimate for earnings calls for a pandemic-led year-over-year decline of 15.2%. In second-quarter 2020, adjusted earnings of 92 cents per share decreased 45.2% on a year-over-year basis.

What Our Model Says

Our proven model predicts an earnings beat for Omnicom this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.

Omnicom has an Earnings ESP of +0.89% and a Zacks Rank #2.

Omnicom Group Inc. Price and EPS Surprise

Omnicom Group Inc. price-eps-surprise | Omnicom Group Inc. Quote

Other Stocks That Warrant a Look

Aptiv APTV has an Earnings ESP of +15.51% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Booz Allen Hamilton BAH has an Earnings ESP of +3.64% and a Zacks Rank #3.

Waste Connections WCN has an Earnings ESP of +0.32% and a Zacks Rank #3.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases.

They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Omnicom Group Inc. (OMC): Free Stock Analysis Report
 
Waste Connections, Inc. (WCN): Free Stock Analysis Report
 
Booz Allen Hamilton Holding Corporation (BAH): Free Stock Analysis Report
 
Aptiv PLC (APTV): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue